Anti-angiogenic therapy for glioma: Puzzle and hope

Anti-angiogenic therapy for glioma: Puzzle and hope

Glioma is one of the most common primary malignant tumors in the central nervous system and glioblastoma (GBM) is the deadly disease. Excessive angiogenesis and adequate blood supply result in rapid proliferation and invasion in GBM. Therefore, targeting angiogenesis may be an effective way to inhib...

Full description

Bibliographic Details
Main Author: Zhong-ping Chen
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Glioma
Subjects:
angiogenesis
anti-angiogenic therapy
glioblastoma
glioma
regulatory factor
survival
targeting therapy
Online Access:http://www.jglioma.com/article.asp?issn=2589-6113;year=2019;volume=2;issue=4;spage=182;epage=184;aulast=Chen

Internet

http://www.jglioma.com/article.asp?issn=2589-6113;year=2019;volume=2;issue=4;spage=182;epage=184;aulast=Chen

Similar Items